Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001784-30Phase 2Completed
Phase 2, open-label, single-arm trial of stiripentol in Dravet syndrome, sponsored by Biocodex. Primary endpoint: Pharmacokinetic parameters of stiripentol at steady state. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001784-30.